Nick Clark, Scientist, Research & Biomarkers, mRNA, Waltham, Massachusetts, US
Nick Clark, Scientist, Research & Biomarkers, mRNA, Waltham, Massachusetts, US
Our Science Stories
We chase the miracles of science to improve people’s lives. But we can’t do it alone. We work closely with healthcare professionals, patient advocates, governments and industry so we can have the biggest impact.
Explore the pathway-led research, industry-leading technology platforms and AI-powered tools driving Sanofi's mission. These stories highlight how our dedicated scientists are pushing the boundaries of medical science to address unmet health needs and deliver life-changing solutions to patients worldwide.
In the Spotlight
January 26, 2026
Two’s Company. Three’s a Crowd. Five Nanobody® Subunits? That Could Be a New Medicine.
January 6, 2026
Our Human-Centric Approach to Partnership Amidst an Evolving Biotech Landscape
October 7, 2025
How Sanofi is Rewriting the Script for Untreated Rare Diseases
AI Across R&D
February 24, 2026
AI Across the R&D Value Chain: Portfolio Decision-Making
January 13, 2026
AI Across the R&D Value Chain: Manufacturing - Digital Labs and Self-Sharpening Tools
September 4, 2025
AI Across the R&D Value Chain: Clinical Development
July 9, 2025
AI Across the R&D Value Chain: Drug Discovery
Everything About Our Science
June 11, 2026
Making it Real: Turning New Scientific Breakthroughs into Reality for Patients
June 11, 2026
The Need to Reframe Disease Control in Immune Thrombocytopenia (ITP)
May 22, 2026
Redefining What’s Possible Through Gastroenterology Research
May 20, 2026
Beyond Clinical Trials: Listening Is the Work
May 20, 2026
Designing Trials That Reflect Real Lives
April 20, 2026
Shape Matters: Inside Molecular Clamp Vaccines
April 3, 2026
The Fast (And Intense) Lane: How Expedited Approvals Are Going Further and Faster for Patients
January 26, 2026
Two’s Company. Three’s a Crowd. Five Nanobody® Subunits? That Could Be a New Medicine.
January 6, 2026